ELVN holders · CITADEL ADVISORS LLC 13F · ELVN stock
CITADEL ADVISORS LLC Enliven Therapeutics Inc. (ELVN) 13F holding
CITADEL ADVISORS LLC reported 1,743,915 ELVN shares valued at $68.4M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.
This is the newest ELVN 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the ELVN holders table.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 1,743,915 | $68.4M | COM |
| 2025-12-31 | 1,424,344 | $21.9M | COM |
| 2025-09-30 | 1,160,503 | $23.8M | COM |
| 2025-06-30 | 1,470,424 | $29.5M | COM |
Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.